MYC and neoplasm: The use of a dm6A clustered regularly interspaced short palindromic repeats (CRISPR) system in tumor cells to target the RNA of the oncogene EGFR/MYC can significantly reduce its expression level and inhibit the growth of tumor cells, thus revealing the potential value of the dm6A CRISPR system in cancer treatment [197].